These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 28930549)
21. Erythropoietin-activated mesenchymal stem cells promote healing ulcers by improving microenvironment. Lu H; Wu X; Wang Z; Li L; Chen W; Yang M; Huo D; Zeng W; Zhu C J Surg Res; 2016 Oct; 205(2):464-473. PubMed ID: 27664897 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of intralesional recombinant human epidermal growth factor in chronic diabetic foot ulcers. Dumantepe M; Fazliogullari O; Seren M; Uyar I; Basar F Growth Factors; 2015 Apr; 33(2):128-32. PubMed ID: 25856197 [TBL] [Abstract][Full Text] [Related]
23. Granulation response and partial wound closure predict healing in clinical trials on advanced diabetes foot ulcers treated with recombinant human epidermal growth factor. Valenzuela-Silva CM; Tuero-Iglesias ÁD; García-Iglesias E; González-Díaz O; Del Río-Martín A; Yera Alos IB; Fernández-Montequín JI; López-Saura PA Diabetes Care; 2013 Feb; 36(2):210-5. PubMed ID: 22966096 [TBL] [Abstract][Full Text] [Related]
24. The use of plasma rich in growth factors (PRGF-Endoret) in the treatment of a severe mal perforant ulcer in the foot of a person with diabetes. Orcajo B; Muruzabal F; Isasmendi MC; Gutierrez N; Sánchez M; Orive G; Anitua E Diabetes Res Clin Pract; 2011 Aug; 93(2):e65-e67. PubMed ID: 21546112 [TBL] [Abstract][Full Text] [Related]
25. [Research progress of dipeptidyl peptidase 4 inhibitors on healing of chronic diabetic foot ulcers]. Gao Y; Liang Y; Ran X Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 May; 32(5):630-633. PubMed ID: 29806355 [TBL] [Abstract][Full Text] [Related]
26. [Effects of San-huang-sheng-fu oil on peripheral circulatory disorders and foot ulcers in diabetic rats and the mechanisms]. Wan Y; Yang YJ; Li YS; Li XJ; Zhang W; Liu M; Tang HB Zhonghua Shao Shang Za Zhi; 2016 Mar; 32(3):168-75. PubMed ID: 27030654 [TBL] [Abstract][Full Text] [Related]
27. Effects of insulin on the skin: possible healing benefits for diabetic foot ulcers. Emanuelli T; Burgeiro A; Carvalho E Arch Dermatol Res; 2016 Dec; 308(10):677-694. PubMed ID: 27655635 [TBL] [Abstract][Full Text] [Related]
28. [Clinical study of various growth factors on the improvement of impaired healing ulcers in patients with diabetic disease]. Feng J; Du WH; Wang J Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1999 Sep; 13(5):273-7. PubMed ID: 12080817 [TBL] [Abstract][Full Text] [Related]
29. Wound healing effects of dipeptidyl peptidase-4 inhibitors: An emerging concept in management of diabetic foot ulcer-A review. Saboo A; Rathnayake A; Vangaveti VN; Malabu UH Diabetes Metab Syndr; 2016; 10(2):113-9. PubMed ID: 25990796 [TBL] [Abstract][Full Text] [Related]
30. [Study on the mechanism of autologous platelet-rich gel to treat the refractory diabetic dermal ulcers]. Yuan NB; Long Y; Zhang XX; Ran XW Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):292-4. PubMed ID: 19462910 [TBL] [Abstract][Full Text] [Related]
31. Use of topical recombinant human platelet-derived growth factor-BB (becaplermin) in healing of chronic mixed arteriovenous lower extremity diabetic ulcers. Miller MS J Foot Ankle Surg; 1999; 38(3):227-31. PubMed ID: 10384364 [TBL] [Abstract][Full Text] [Related]
32. Topical application of nerve growth factor in human diabetic foot ulcers. A study of three cases. Generini S; Tuveri MA; Matucci Cerinic M; Mastinu F; Manni L; Aloe L Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):542-4. PubMed ID: 15505764 [TBL] [Abstract][Full Text] [Related]
33. Fibroblast Growth Factor in Diabetic Foot Ulcer: Progress and Therapeutic Prospects. Liu Y; Liu Y; Deng J; Li W; Nie X Front Endocrinol (Lausanne); 2021; 12():744868. PubMed ID: 34721299 [TBL] [Abstract][Full Text] [Related]
34. Multicenter Clinical Trials Analyzing Efficacy and Safety of Topical Cortex Phellodendri Compound Fluid in Treatment of Diabetic Foot Ulcers. Liu Y; Li Y; Du Y; Huang T; Zhu C Med Sci Monit; 2020 Aug; 26():e923424. PubMed ID: 32817595 [TBL] [Abstract][Full Text] [Related]
35. Protocol for treatment of diabetic foot ulcers. Brem H; Sheehan P; Boulton AJ Am J Surg; 2004 May; 187(5A):1S-10S. PubMed ID: 15147985 [TBL] [Abstract][Full Text] [Related]
36. Novel biological therapies for the treatment of diabetic foot ulcers. Adeghate J; Nurulain S; Tekes K; Fehér E; Kalász H; Adeghate E Expert Opin Biol Ther; 2017 Aug; 17(8):979-987. PubMed ID: 28532226 [TBL] [Abstract][Full Text] [Related]
37. Appropriate analysis and presentation of data in wound healing studies: should we publish individual patient data? Uzun G; Mutluoglu M; Yildiz S Wound Repair Regen; 2014; 22(6):765-6. PubMed ID: 25327212 [No Abstract] [Full Text] [Related]
39. Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights. Baltzis D; Eleftheriadou I; Veves A Adv Ther; 2014 Aug; 31(8):817-36. PubMed ID: 25069580 [TBL] [Abstract][Full Text] [Related]
40. [Mechanisms of adrenergic β-antagonist for wounds and its application prospect in diabetic foot ulcers]. Sun S; Ma J; Ran X Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2020 Dec; 34(12):1630-1634. PubMed ID: 33319548 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]